The store will not work correctly when cookies are disabled.
5-(3-Trifluoromethyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA431400
PubChem CID: 10470867
Max Phase: Preclinical
Molecular Formula: C18H13F3N2
Molecular Weight: 314.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1cccc(C2=Cc3ccccc3C3=NCCN23)c1
Standard InChI: InChI=1S/C18H13F3N2/c19-18(20,21)14-6-3-5-13(10-14)16-11-12-4-1-2-7-15(12)17-22-8-9-23(16)17/h1-7,10-11H,8-9H2
Standard InChI Key: WAPIGQCOZADHIY-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
1.7875 -1.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2750 -2.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8167 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -1.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6167 -2.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7542 -1.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2750 -2.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7750 -1.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4167 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7167 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8917 -2.8375 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.3917 -2.9500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.2375 -2.4625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 -2.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3042 -2.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7125 -0.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2250 -2.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2625 -0.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6125 -1.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3042 -0.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2875 -1.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2708 -1.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 10 1 0
6 2 1 0
7 2 2 0
8 4 1 0
9 3 1 0
10 11 1 0
11 9 2 0
12 5 1 0
13 5 1 0
14 5 1 0
15 1 1 0
16 15 1 0
17 9 1 0
18 6 1 0
19 8 1 0
20 21 1 0
21 17 2 0
22 18 2 0
23 19 2 0
7 16 1 0
6 8 2 0
10 20 2 0
23 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.31 | Molecular Weight (Monoisotopic): 314.1031 | AlogP: 4.28 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.10 | CX LogP: 3.94 | CX LogD: 3.76 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.77 | Np Likeness Score: -0.71 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |